Navigation Links
FDA Panel Recommends Against 1st Drug for Chronic Fatigue Syndrome
Date:12/21/2012

By Steven Reinberg
HealthDay Reporter

FRIDAY, Dec. 21 (HealthDay News) -- A U.S. Food and Drug Administration advisory committee on Thursday recommended against approval of the first proposed drug to treat chronic fatigue syndrome.

The advisors weighed the risks and benefits associated with the intravenous drug rintatolimod (suggested brand name Ampligen). The drug's maker, Hemispherx Biopharma of Philadelphia, also failed to win FDA approval in 2009 because of concerns about the methodology of clinical trials used to study the drug.

In Thursday's 8-to-5 vote, the advisory panel said the company hadn't provided enough data to support the approval of Ampligen. Although the FDA isn't bound to follow the recommendations of its advisory committees it usually does so.

The central issue Thursday was whether Ampligen works and is safe. The FDA said there wasn't sufficient data in clinical trials to determine the drug's safety. Possible concerns include infections and liver problems, The Wall Street Journal reported.

Several panel members said they struggled with their decisions because it seems the drug works in some patients, the newspaper reported.

Experts have said they would welcome a treatment for chronic fatigue syndrome, a disabling condition that affects as many as 4 million Americans, mostly women. There is no cure, but Ampligen appears to reduce symptoms for some patients.

"It does seem to help at least a subset of patients significantly. For others, there isn't a significant response," said K. Kimberly McCleary, president of the Chronic Fatigue and Immune Dysfunction Syndrome Association of America.

"This drug has been studied in chronic fatigue syndrome since the late 1980s, so it's been around for a while," McCleary added.

Dr. Nancy Klimas, professor of medicine at Nova Southeastern University College of Osteopathic Medicine in Fort Lauderdale, Fla., who is part of a
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. FDA Panel Considers 1st Drug for Chronic Fatigue Syndrome
2. CDC Panel: All Pregnant Women Should Get Whooping Cough Shot
3. U.S. Panel Rejects Ovarian Cancer Screens for Low-Risk Women
4. Expert panel calls for new research approach to prevent youth violence
5. Expert Panel Suggests PSA Test May Benefit Some Men
6. Few Patients Should Get Metal-on-Metal Hip Implants, FDA Panel Says
7. Screen All Adults for Obesity: U.S. Panel
8. FDA Panel Backs At-Home HIV Test
9. FDA Panel to Consider At-Home HIV Test
10. FDA Panel Gives Blessing to New Weight-Loss Drug
11. U.S. Panel Rejects Ovarian Cancer Screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... MillionaireCasket.com is a professional supplier of funeral ... caskets are selling well in the global market. Recently, the ... and launched a special offer for all the newly ... the company’s cherry caskets are made with superb materials. As ... people to show respect to the departed saint. MillionaireCasket.com is ...
(Date:7/13/2014)... Failure to get the best treatment and variations in ... why survival for blood cancer patients still varies widely ... study of survival in European adults to date, published ... news is that 5-year survival for most cancers of ... most likely reflecting the approval of new targeted drugs ...
(Date:7/13/2014)... 13, 2014 Carolinas Healthcare System celebrated ... the Carolinas HealthCare System - Anson located in Anson ... Anson Community Hospital in Wadesboro. , Located on U.S. ... from the previous facility. Situated on a 10-acre site, ... an emergency room drop-off, helipad, healing garden, and 15 ...
(Date:7/13/2014)... identifies a novel genetic and molecular pathway ... opening up potential new therapeutic strategies for an ... is a chronic inflammatory disorder of the esophagus. ... certain foods and an over-accumulation in the esophagus ... the body,s immune system). EoE can cause a ...
(Date:7/13/2014)... Chromatography system is a physical method of separation ... samples such as air and water. Chromatography systems ... namely mobile phase and stationary phase. The components ... phase, followed by the differential rate of migration ... mixture. Chromatography system plays an important role in ...
Breaking Medicine News(10 mins):Health News:Brand New Cherry Caskets Unveiled By China Casket Supplier MillionaireCasket.com 2Health News:The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe 2Health News:The Lancet Oncology: Differences in treatment likely to be behind differing survival rates for blood cancers between regions within Europe 3Health News:Carolinas HealthCare System - Anson Hospital Now Open 2Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 2Health News:Study finds cause of mysterious food allergy, suggests new treatment strategy 3Health News:North America Chromatography Systems Market Is Expected to Reach $6593.4 Million by 2018 - New Report by MicroMarket Monitor 2Health News:North America Chromatography Systems Market Is Expected to Reach $6593.4 Million by 2018 - New Report by MicroMarket Monitor 3
... Aug. 31 During a campaign stop,in the Palmetto ... say how he would address America,s health care crisis, ... states to decide. [Associated Press,8/31/07] Yet, in the face ... overtime to distance himself from the Massachusetts,health care plan ...
... reduction over 6 weeks , , FRIDAY, Aug. 31 (HealthDay News) ... hot flashes of menopause, Mayo Clinic researchers report. , A ... who used dietary flaxseed daily reported a 50 percent reduction ... "Flaxseed worked very well," said Dr. Sandhya Pruthi, director of ...
... vital role in maintaining blood supply, WASHINGTON, Aug. ... difficult season for blood collection, and one that blood,centers ... tight blood,supplies since Memorial Day, there is relief in ... school blood drives. (PHOTO: http://www.newscom.com/cgi-bin/prnh/20070831/DCF008 ) ...
... MINNEAPOLIS, Aug. 31 HEI, Inc. (Nasdaq: ... has entered into an agreement,to sell substantially all ... Smartrac,Technology US, Inc., a wholly-owned subsidiary of Dutch ... sale of substantially all the assets of,the RFID ...
... 31 Landauer, Inc. (NYSE:,LDR) announced today that its ... $0.475 per share for the fourth quarter of,fiscal 2007. ... to shareholders,of record on September 14, 2007. About ... services to determine,occupational and environmental radiation exposure. For more ...
... MYL ) ("Mylan") announced today that it is ... of its outstanding 5.750% Senior Notes due,2010 (CUSIP No. ... 628530AC1) (collectively, the "Notes"). Mylan is making the ... its new global capital structure and in preparation for ...
Cached Medicine News:Health News:DNC: South Carolina Rejecting Romney's Smooth Talk on Health Care 2Health News:Flaxseed May Relieve Hot Flashes 2Health News:Back to School Means Return of School Blood Drives 2Health News:Back to School Means Return of School Blood Drives 3Health News:HEI, Inc. Announces Sale of RFID Division Assets 2Health News:Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Merck's Generic Pharmaceutical Business 2Health News:Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Merck's Generic Pharmaceutical Business 3Health News:Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Merck's Generic Pharmaceutical Business 4
(Date:7/10/2014)... 2014  Decision Resources Group finds that while ... specialists are willing to prescribe Durata,s Dalvance (dalbavancin) ... as OPAT, approximately two-thirds of the respondents reported ... hospital inpatients. However, our findings indicate that nearly ... on OPAT following hospital discharge, and most are ...
(Date:1/15/2014)... MILTON, N.Y. , Jan. 15, 2014 Sono-Tek Corporation ... three months ended November 30, 2013, compared to sales of ... or 20%. Once again, this quarter has also shown growth ... in the first quarter of this fiscal year. Markets that ...
(Date:1/15/2014)... , Jan. 15, 2014 As health officials across the ... select Meijer pharmacies in Michigan will ... eligible patients, enabling Meijer pharmacists to administer tests and, in ... by a physician participating in the study. The ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3
Clearview Chlamydia is a rapid, easy-to-use test for the detection of Chlamydia trachomatis from female endocervical swab specimens....
One inch disposable patch electrode uses a specially formulated adhesive solid gel. Reusable lead wire with snap connector provides economic benefits. Ideal for sleep studies where leg movement or EK...
One inch disposable patch electrode uses a specially formulated adhesive solid gel. Reusable lead wire with snap connector provides economic benefits. Ideal for sleep studies where leg movement or EK...
... Made with elastic fabric, these head cap ... need to begin testing. Each Electro-Cap System ... the International 10-20 System. When you place ... are using with your head cap system ...
Medicine Products: